Frontlight ResearchEarly access
CompletedNo phase
Sarcopenia and Peripheral Artery Disease With Chronic Limb Threatening Ischemia
Key facts
- Who runs it
- Fudan University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 97 people enrolled
- Started
- 1 Jan 2023
- Ended
- 31 Dec 2024
- Type of study
- Observational
- Treatments tested
- Not applicable- observational study
- Record updated
- 26 June 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients of Peripheral Artery Disease, including intermittent claudication and Chronic Limb Threatening Ischemia
- Patients with Rutherford grade 2-6 between Jan.1 2023 and Dec.31 2024
- Patients at age 18-80
- Patients underwent an in-hospital routine enhanced whole abdomen to lower extremities CT scan
- Patients able to complete the clinical follow-up for 3 months
Who cannot take part
- Poor CT quality or incomplete images
- Incomplete clinical data
- In-hospital mortality during Jan.1 2023 and Dec.31 2024
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To evaluate the correlation of Sarcopenia Parameters and Peripheral Artery Disease with chronic limb threatening ischaemia.
The group in the trial
- patiets with peripheral artery disease
Treatment: Not applicable- observational study
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Correlation of Sarcopenia and Peripheral Artery Disease With Chronic Limb Threatening Ischemia
- Record updated
- 26 June 2025